RESEARCH AND TECHNOLOGY AGREEMENTResearch and Technology Agreement • May 11th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations • Delaware
This Research and Technology Agreement (the “Agreement”) is made effective as of January 24, 2001 (the “Effective Date”) between INTRABIOTICS PHARMACEUTICALS, INC., a Delaware corporation, having its principal place of business in Mountain View, California (hereinafter referred to as “INTRABIOTICS”), and NEW CHEMICAL ENTITIES, INC., a Delaware corporation having a principal place of business in Bothell, Washington (hereinafter referred to as “NCE”).
DRUG DISCOVERY, DEVELOPMENT, AND LICENSE AGREEMENT by and between DIVERSA CORPORATION and INTRABIOTICS PHARMACEUTICALS, INC.License Agreement • May 11th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations • California
THIS DRUG DISCOVERY, DEVELOPMENT, AND LICENSE AGREEMENT, dated and effective as of January 6, 2001 (the “Effective Date”), is by and between DIVERSA CORPORATION, a Delaware corporation (“Diversa”), having its principal place of business at 4955 Directors Place, San Diego, California 92121, and INTRABIOTICS PHARMACEUTICALS, INC., a Delaware corporation (“IBP”), having its principal place of business at 2021 Stierlin Court, Mountain View, California 94043 (collectively, the “Parties”).
